In vitro blastocyst formation of human oocytes obtained from unstimulated and stimulated cycles after vitrification at various maturational stages

Fertil Steril. 2000 Mar;73(3):545-51. doi: 10.1016/s0015-0282(99)00546-4.

Abstract

Objective: To evaluate the developmental competence and chromosomal normality of oocytes vitrified at various times after maturation culture.

Design: In vitro model study.

Setting: A university-affiliated hospital.

Patient(s): Unstimulated women who underwent cesarean section or oophorectomy and infertile women who underwent a long protocol of GnRH stimulation.

Intervention(s): Retrieved oocytes were vitrified at 0 or 48 hours after culture in unstimulated cycles and at 0, 8-15, or 24-28 hours after culture in stimulated cycles.

Main outcome measure(s): Postthaw morphologic normality, maturation, fertilization, cleavage, blastocyst formation, and chromosome number.

Result(s): In the 53 oocytes that were obtained from unstimulated cycles, no statistically significant differences were found in rates of morphologic normality (range, 56%-63%) or fertilization (range, 31%-37%) according to the time of vitrification. In the 50 oocytes that were obtained from stimulated cycles, more of those that were vitrified at 24-28 hours were morphologically normal than those that were vitrified at 0 or 8-15 hours. Regardless of these differences, high cleavage rates (83%-100%) were obtained that did not differ significantly among the treatment groups. In both cycles, 20%-43% of cleaved oocytes developed to the blastocyst stage by 6 days after IVF. All the karyotyped blastocysts, three from unstimulated cycles and four from stimulated cycles, had a normal number of chromosomes.

Conclusion(s): Vitrified and thawed oocytes from unstimulated or stimulated cycles developed to the blastocyst stage, regardless of when vitrification occurred; the number of chromosomes in the blastocysts was normal.

Publication types

  • Research Support, Non-U.S. Gov't

MeSH terms

  • Adult
  • Blastocyst / physiology*
  • Cells, Cultured
  • Chromosome Aberrations
  • Cryopreservation / methods*
  • Culture Techniques / methods
  • Female
  • Fertilization in Vitro / methods*
  • Gonadotropin-Releasing Hormone / agonists
  • Gonadotropin-Releasing Hormone / pharmacology
  • Humans
  • Male
  • Oocytes / drug effects
  • Oocytes / physiology*
  • Ovulation Induction
  • Sex Ratio
  • Sperm Injections, Intracytoplasmic

Substances

  • Gonadotropin-Releasing Hormone